Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy. (Q44750178)
Jump to navigation
Jump to search
scientific article published in January 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy. |
scientific article published in January 2004 |
Statements
Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy (English)
Dietger Niederwieser
Thoralf Lange
Thomas Bumm
Sandra Otto
Haifa-Kathrin Al-Ali
Ines Kovacs
Daniela Krug
Thomas Köhler
Rainer Krahl
Michael W N Deininger
1 January 2004